uniQure (QURE) EBITDA Margin (2016 - 2026)
uniQure's (QURE) quarterly EBITDA Margin came in at 1283.55% in Q1 2026, up 122641.0% year-on-year from N/an in Q1 2025, and down 39.81% quarter-over-quarter from 918.07% in Q4 2025.
uniQure (QURE) EBITDA Margin (2016 - 2026) Analysis & Trends
uniQure's EBITDA Margin history runs 11 years deep, the most recent figure standing at 1283.55% for Q1 2026.
- On a quarterly basis, EBITDA Margin rose 122641.0% year-over-year to 1283.55% in Q1 2026; TTM through Mar 2026 was 1059.74%, a 22118.0% decrease from a year earlier, with the FY2025 full-year figure at 1151.38%, down 51842.0% from the prior year.
- EBITDA Margin declined to 1283.55% in Q1 2026 per QURE's latest filing, from 918.07% in the prior quarter.
- Across five years, EBITDA Margin topped out at 25.79% in Q4 2022 and bottomed at 11279.88% in Q2 2022.
- The 5-year median for EBITDA Margin is 1378.95% (2025), against an average of 2341.01%.
- Across the five-year window, EBITDA Margin plunged 1136568 bps in 2022 and jumped 859309 bps in 2023, its largest moves.
- Year by year, EBITDA Margin stood at 25.79% in 2022, then tumbled by 3679 bps to 923.13% in 2023, then advanced by 5 bps to 877.76% in 2024, then decreased by 5 bps to 918.07% in 2025, then tumbled by 40 bps to 1283.55% in 2026.
- Per Business Quant, the three latest QURE EBITDA Margin figures stand at 1283.55% (Q1 2026), 918.07% (Q4 2025), and 1378.95% (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 16.51% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 38.10% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 17.83% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 31.68% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | uniQure | 2.47 Bn | 2.47 Bn | 3.34 Mn | -1,283.55% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,283.55% |
| Dec 31, 2025 | -918.07% |
| Sep 30, 2025 | -1,378.95% |
| Jun 30, 2025 | -833.62% |
| Mar 31, 2025 | -2,509.96% |
| Dec 31, 2024 | -877.76% |
| Sep 30, 2024 | -1,758.99% |
| Jun 30, 2024 | -395.56% |
| Mar 31, 2024 | -639.10% |
| Dec 31, 2023 | -923.13% |
| Sep 30, 2023 | -5,819.26% |
| Jun 30, 2023 | -2,686.79% |
| Mar 31, 2023 | -1,392.90% |
| Dec 31, 2022 | 25.79% |
| Sep 30, 2022 | -4,107.52% |
| Jun 30, 2022 | -11,279.88% |
| Mar 31, 2022 | -3,017.86% |
| Dec 31, 2021 | 3.58% |
| Sep 30, 2021 | -2,262.44% |
| Jun 30, 2021 | 85.80% |